Journal Watch · Nature Chemical Biology · 2026

Halting translation by the letter with sequence-selective small molecules.

In this Review, we summarize recent findings on sequence-selective translation modulators, with emphasis on eukaryotes, the techniques that enabled their discovery, and offer an outlook into their potential applications.

Schneider-Poetsch T, Yoshida M, Ito T, Iwasaki SNature Chemical Biology3 min readPharma relevance 40/100

DOI: 10.1038/s41589-026-02318-7PMID: 42791378Study type: review / perspective

TL;DR

In this Review, we summarize recent findings on sequence-selective translation modulators, with emphasis on eukaryotes, the techniques that enabled their discovery, and offer an outlook into their potential applications.

Key findings

  • These molecules present exciting opportunities to better understand the translation machinery and provide new venues to modulate the expression of certain protein subpopulations.
  • In this Review, we summarize recent findings on sequence-selective translation modulators, with emphasis on eukaryotes, the techniques that enabled their discovery, and offer an outlook into their potential applications.

What they did

Since the discovery of antibiotics inhibiting bacterial protein synthesis, small molecules have served as probes to dissect the translation apparatus and as medications to fight disease. Advances in sequencing-based techniques and structural methods now provide for a highly detailed mechanistic understanding. Recent evidence shows that many translation modulators act in an RNA- or a peptide-sequence-selective manner.

Full abstract (original)

Background: Protein synthesis forms the very basis of life. Cells rely on a sophisticated machinery of factors for the translation of an RNA template into a correct amino acid sequence. We owe a lot of our understanding of this process to specific small-molecule modulators.

What they did: Since the discovery of antibiotics inhibiting bacterial protein synthesis, small molecules have served as probes to dissect the translation apparatus and as medications to fight disease. Advances in sequencing-based techniques and structural methods now provide for a highly detailed mechanistic understanding. Recent evidence shows that many translation modulators act in an RNA- or a peptide-sequence-selective manner.

Results & conclusions: These molecules present exciting opportunities to better understand the translation machinery and provide new venues to modulate the expression of certain protein subpopulations. In this Review, we summarize recent findings on sequence-selective translation modulators, with emphasis on eukaryotes, the techniques that enabled their discovery, and offer an outlook into their potential applications.

Abstract © the authors / Nature Chemical Biology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41589-026-02318-7 · PubMed 42791378.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • As a review, this paper synthesises prior studies rather than reporting new experimental data; weight it accordingly.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Chemical Biology study find?

In this Review, we summarize recent findings on sequence-selective translation modulators, with emphasis on eukaryotes, the techniques that enabled their discovery, and offer an outlook into their potential applications.

What type of study is this?

It is a review / perspective, published in Nature Chemical Biology in 2026. Since the discovery of antibiotics inhibiting bacterial protein synthesis, small molecules have served as probes to dissect the translation apparatus and as medications to fight disease.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41589-026-02318-7. PubMed ID: 42791378. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Schneider-Poetsch T, Yoshida M, Ito T, Iwasaki S. Halting translation by the letter with sequence-selective small molecules.. Nature Chemical Biology (2026). DOI: 10.1038/s41589-026-02318-7.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/halting-translation-by-the-letter-with-sequence-selective-small-molecule-023187/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides